Tongxinluo Improve High on Clopidogrel Platelet Reactivity Patients With Coronary Heart Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 134 participants.

Also called NCT01721590

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 134 participants (enrolled count) (from the registry)
Sponsor
Han Yaling (from the registry)
Registry
  • NCT NCT01721590
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01721590. Randomized; double masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2013-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Tongxinluo Improve High on Clopidogrel Platelet Reactivity Patients With Coronary Heart Disease
Acronym
Talent
Intervention (Drug)
Tongxinluo
Intervention (Drug)
placebo
Lead sponsor
Han Yaling (class: other)

Record details

Record id
cardio:ct-nct01721590
Content hash
5792194737a4a03d98a4ea8075ffe4c8654606068934096178d295f717e5cb42